• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于开源安卓的人工胰腺的计算机模拟试验:一种测试 DIY 系统安全性和有效性的新模式。

In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems.

机构信息

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.

CLOSED LOOP Systems, Prague, Czech Republic, Prague, Czech Republic.

出版信息

Diabetes Technol Ther. 2020 Feb;22(2):112-120. doi: 10.1089/dia.2019.0375. Epub 2019 Dec 17.

DOI:10.1089/dia.2019.0375
PMID:31769699
Abstract

Safety data on Do-It-Yourself Artificial Pancreas Systems are missing. The most widespread in Europe is the AndroidAPS implementation of the OpenAPS algorithm. We used the UVA/Padova Type 1 Diabetes Simulator to in silico test safety and efficacy of this algorithm in different scenarios. We tested five configurations of the AndroidAPS algorithm differing in aggressiveness and patient's interaction with the system. All configurations were tested with insulin sensitivity variation of ±30%. The most promising configurations were tested in real-life scenarios: over- and underestimated bolus by 50%, bolus delivered 15 min before meal, and late bolus delivered 15 min after meal. Continuous Glucose Monitoring (CGM) time in ranges (TIRs) metrics were used to assess the glycemic control. In silico testing showed that open-source closed-loop system AndroidAPS works effectively and safely. The best results were reached if AndroidAPS algorithm worked with microboluses and when half of calculated bolus was issued (mean glycemia 131 mg/dL, SD 27 mg/dL, TIR 91%, time between 54 and 70 mg/dL <1%, and low blood glucose index even <1). The meal bolus over- and underestimation as well as late bolus did not affect the TIR and, importantly, the time between 54 and 70 mg/dL. In silico testing proved that AndroidAPS implementation of the OpenAPS algorithm is safe and effective, and it showed a great potential to be tested in prospective home setting study.

摘要

DIY 人工胰腺系统的安全性数据缺失。在欧洲应用最广泛的是 AndroidAPS 实现的 OpenAPS 算法。我们使用 UVA/Padova 1 型糖尿病模拟器对该算法在不同场景下的安全性和有效性进行了计算机模拟测试。我们测试了 AndroidAPS 算法的五种不同激进程度和患者与系统交互方式的配置。所有配置都在胰岛素敏感性变化±30%的情况下进行了测试。最有前途的配置在现实场景中进行了测试:餐前和餐后 50%的超量和低估推注、提前 15 分钟推注和延迟 15 分钟推注。连续血糖监测(CGM)时间范围内(TIR)指标用于评估血糖控制。计算机模拟测试表明,开源闭环系统 AndroidAPS 有效且安全。如果 AndroidAPS 算法与微推注一起工作并且只发布计算推注的一半(平均血糖 131mg/dL,SD 27mg/dL,TIR 91%,54-70mg/dL 之间的时间<1%,低血糖指数甚至<1),则可以达到最佳效果。餐前和餐后推注的高估和低估以及延迟推注均不会影响 TIR,重要的是,54-70mg/dL 之间的时间也不会受到影响。计算机模拟测试证明,OpenAPS 算法的 AndroidAPS 实现是安全有效的,并且具有在前瞻性家庭环境研究中进行测试的巨大潜力。

相似文献

1
In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems.基于开源安卓的人工胰腺的计算机模拟试验:一种测试 DIY 系统安全性和有效性的新模式。
Diabetes Technol Ther. 2020 Feb;22(2):112-120. doi: 10.1089/dia.2019.0375. Epub 2019 Dec 17.
2
Efficient Closed Loop Simulation of Do-It-Yourself Artificial Pancreas Systems.DIY 人工胰腺系统的高效闭环模拟。
J Diabetes Sci Technol. 2022 Jan;16(1):61-69. doi: 10.1177/19322968211032249. Epub 2021 Jul 30.
3
An In Silico Head-to-Head Comparison of the Do-It-Yourself Artificial Pancreas Loop and Bio-Inspired Artificial Pancreas Control Algorithms.一种 DIY 人工胰腺闭环与仿生人工胰腺控制算法的计算机模拟头对头比较。
J Diabetes Sci Technol. 2022 Jan;16(1):29-39. doi: 10.1177/19322968211060074. Epub 2021 Dec 3.
4
Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.闭环多模型概率预测控制器人工胰腺在监督下的宾馆环境中对青少年和成年人的性能。
Diabetes Technol Ther. 2018 May;20(5):335-343. doi: 10.1089/dia.2017.0424. Epub 2018 Apr 16.
5
Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.高级混合人工胰腺系统提高了对未通知用餐的反应能力-与当前可用系统的模拟比较。
Comput Methods Programs Biomed. 2021 Nov;211:106401. doi: 10.1016/j.cmpb.2021.106401. Epub 2021 Sep 13.
6
Full closed loop open-source algorithm performance comparison in pigs with diabetes.猪糖尿病全闭环开源算法性能比较。
Clin Transl Med. 2021 Apr;11(4):e387. doi: 10.1002/ctm2.387.
7
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.1型糖尿病的多中心闭环/混合餐时大剂量胰岛素输注
Diabetes Technol Ther. 2014 Oct;16(10):623-32. doi: 10.1089/dia.2014.0050. Epub 2014 Sep 4.
8
Pre-school and school-aged children benefit from the switch from a sensor-augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis.学龄前和学龄儿童从传感器增强型胰岛素输注泵切换到 AndroidAPS 混合闭环系统中获益:一项回顾性分析。
Pediatr Diabetes. 2021 Jun;22(4):594-604. doi: 10.1111/pedi.13190. Epub 2021 Feb 25.
9
Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial.中国 1 型糖尿病成人患者家庭使用 Android 人工胰腺系统的疗效和安全性:一项 26 周、自由生活、随机、开放标签、双臂、两阶段、交叉试验的方案。
BMJ Open. 2023 Aug 9;13(8):e073263. doi: 10.1136/bmjopen-2023-073263.
10
Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.1型糖尿病患者模型预测控制的逐次运行调整:计算机模拟试验
J Diabetes Sci Technol. 2009 Sep 1;3(5):1091-8. doi: 10.1177/193229680900300512.

引用本文的文献

1
Real-time converter of intermittent-scanned glucose sensors to continuous glucose monitors with potential future applications for insulin delivery.间歇性扫描葡萄糖传感器向连续葡萄糖监测仪的实时转换器,在胰岛素输送方面具有潜在的未来应用前景。
HardwareX. 2025 Aug 19;23:e00684. doi: 10.1016/j.ohx.2025.e00684. eCollection 2025 Sep.
2
Examining the Emotional and Physical Health Impact in Users of Open-Source Automated Insulin Delivery and Sources of Support: Qualitative Analysis of Patient Narratives.探究开源自动胰岛素输送用户的情绪和身体健康影响及支持来源:患者叙述的定性分析
J Med Internet Res. 2025 Jan 6;27:e48406. doi: 10.2196/48406.
3
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin Delivery.
国际儿童和青少年糖尿病学会2024年临床实践共识指南:糖尿病技术 - 胰岛素输注
Horm Res Paediatr. 2024;97(6):636-662. doi: 10.1159/000543034. Epub 2024 Dec 10.
4
The Evolution of Insulin Administration in Type 1 Diabetes.1型糖尿病胰岛素给药的演变
J Diabetes Mellitus. 2021 Nov;11(5):249-277. doi: 10.4236/jdm.2021.115021. Epub 2021 Nov 17.
5
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility.开发 UVA/Padova 1 型糖尿病模拟器:建模、验证、改进和应用。
J Diabetes Sci Technol. 2023 Nov;17(6):1493-1505. doi: 10.1177/19322968231195081. Epub 2023 Sep 25.
6
Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial.中国 1 型糖尿病成人患者家庭使用 Android 人工胰腺系统的疗效和安全性:一项 26 周、自由生活、随机、开放标签、双臂、两阶段、交叉试验的方案。
BMJ Open. 2023 Aug 9;13(8):e073263. doi: 10.1136/bmjopen-2023-073263.
7
A systematic review of cardiac clinical trials.一项关于心脏临床试验的系统评价。
Prog Biomed Eng (Bristol). 2023 Jul 1;5(3):032004. doi: 10.1088/2516-1091/acdc71. Epub 2023 Jun 22.
8
The First Regulatory Clearance of an Open-Source Automated Insulin Delivery Algorithm.首个开源自动化胰岛素输送算法的监管批准。
J Diabetes Sci Technol. 2023 Sep;17(5):1139-1141. doi: 10.1177/19322968231164166. Epub 2023 Apr 13.
9
In-silico evaluation of an artificial pancreas achieving automatic glycemic control in patients with type 1 diabetes.1 型糖尿病患者自动血糖控制的人工胰腺的计算机模拟评估。
Front Endocrinol (Lausanne). 2023 Jan 30;14:1115436. doi: 10.3389/fendo.2023.1115436. eCollection 2023.
10
Accuracy of an Off-Label Transmitter and Data Manager Paired With an Intermittent Scanned Continuous Glucose Monitor in Adults With Type 1 Diabetes.标签外传输器和数据管理器与间歇性扫描连续血糖监测仪在 1 型糖尿病成人中的准确性。
J Diabetes Sci Technol. 2024 May;18(3):701-708. doi: 10.1177/19322968221133405. Epub 2022 Oct 25.